119 related articles for article (PubMed ID: 12515556)
21. Critical amino acid substitutions in the Src SH3 domain that convert c-Src to be oncogenic.
Miyazaki K; Senga T; Matsuda S; Tanaka M; Machida K; Takenouchi Y; Nimura Y; Hamaguchi M
Biochem Biophys Res Commun; 1999 Oct; 263(3):759-64. PubMed ID: 10512753
[TBL] [Abstract][Full Text] [Related]
22. Why ligand cross-reactivity is high within peptide recognition domain families? A case study on human c-Src SH3 domain.
He P; Wu W; Wang HD; Liao KL; Zhang W; Lv FL; Yang K
J Theor Biol; 2014 Jan; 340():30-7. PubMed ID: 24021866
[TBL] [Abstract][Full Text] [Related]
23. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.
Nam NH; Pitts RL; Sun G; Sardari S; Tiemo A; Xie M; Yan B; Parang K
Bioorg Med Chem; 2004 Feb; 12(4):779-87. PubMed ID: 14759738
[TBL] [Abstract][Full Text] [Related]
24. Quaternary structure sensitive tyrosine residues in human hemoglobin: UV resonance raman studies of mutants at alpha140, beta35, and beta145 tyrosine.
Nagai M; Wajcman H; Lahary A; Nakatsukasa T; Nagatomo S; Kitagawa T
Biochemistry; 1999 Jan; 38(4):1243-51. PubMed ID: 9930984
[TBL] [Abstract][Full Text] [Related]
25. Reexamination of the recognition preference of the specificity pocket of the Abl SH3 domain.
Santamaria F; Wu Z; Boulègue C; Pál G; Lu W
J Mol Recognit; 2003; 16(3):131-8. PubMed ID: 12833568
[TBL] [Abstract][Full Text] [Related]
26. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
Liu J; Li M; Ran X; Fan JS; Song J
Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
[TBL] [Abstract][Full Text] [Related]
27. Site-directed mutagenesis of conserved C-terminal tyrosine and tryptophan residues of PsbO, the photosystem II manganese-stabilizing protein, alters its activity and fluorescence properties.
Wyman AJ; Popelkova H; Yocum CF
Biochemistry; 2008 Jun; 47(24):6490-8. PubMed ID: 18500826
[TBL] [Abstract][Full Text] [Related]
28. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
Ren SY; Xue F; Feng J; Skorski T
Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
[TBL] [Abstract][Full Text] [Related]
29. Quaternary structure sensitive tyrosine interactions in hemoglobin: a UV resonance Raman study of the double mutant rHb (beta99Asp-->Asn, alpha42Tyr-->Asp).
Huang S; Peterson ES; Ho C; Friedman JM
Biochemistry; 1997 May; 36(20):6197-206. PubMed ID: 9166792
[TBL] [Abstract][Full Text] [Related]
30. Relationship between hydrophobic interactions and secondary structure stability for Trpzip beta-hairpin peptides.
Takekiyo T; Wu L; Yoshimura Y; Shimizu A; Keiderling TA
Biochemistry; 2009 Feb; 48(7):1543-52. PubMed ID: 19173596
[TBL] [Abstract][Full Text] [Related]
31. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions.
Weng Z; Rickles RJ; Feng S; Richard S; Shaw AS; Schreiber SL; Brugge JS
Mol Cell Biol; 1995 Oct; 15(10):5627-34. PubMed ID: 7565714
[TBL] [Abstract][Full Text] [Related]
32. 4-Fluoroproline derivative peptides: effect on PPII conformation and SH3 affinity.
Ruzza P; Siligardi G; Donella-Deana A; Calderan A; Hussain R; Rubini C; Cesaro L; Osler A; Guiotto A; Pinna LA; Borin G
J Pept Sci; 2006 Jul; 12(7):462-71. PubMed ID: 16506148
[TBL] [Abstract][Full Text] [Related]
33. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
[TBL] [Abstract][Full Text] [Related]
34. Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors.
Lange G; Lesuisse D; Deprez P; Schoot B; Loenze P; Bénard D; Marquette JP; Broto P; Sarubbi E; Mandine E
J Med Chem; 2003 Nov; 46(24):5184-95. PubMed ID: 14613321
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a novel weak interaction between MUC1 and Src-SH3 using nuclear magnetic resonance spectroscopy.
Gunasekara N; Sykes B; Hugh J
Biochem Biophys Res Commun; 2012 May; 421(4):832-6. PubMed ID: 22554509
[TBL] [Abstract][Full Text] [Related]
37. Src proteins/src genes: from sponges to mammals.
Cetkovic H; Grebenjuk VA; Müller WE; Gamulin V
Gene; 2004 Nov; 342(2):251-61. PubMed ID: 15527984
[TBL] [Abstract][Full Text] [Related]
38. Identification and specificity studies of small-molecule ligands for SH3 protein domains.
Inglis SR; Stojkoski C; Branson KM; Cawthray JF; Fritz D; Wiadrowski E; Pyke SM; Booker GW
J Med Chem; 2004 Oct; 47(22):5405-17. PubMed ID: 15481978
[TBL] [Abstract][Full Text] [Related]
39. Phage display selection of ligand residues important for Src homology 3 domain binding specificity.
Rickles RJ; Botfield MC; Zhou XM; Henry PA; Brugge JS; Zoller MJ
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10909-13. PubMed ID: 7479908
[TBL] [Abstract][Full Text] [Related]
40. Recognition of non-canonical peptides by the yeast Fus1p SH3 domain: elucidation of a common mechanism for diverse SH3 domain specificities.
Kim J; Lee CD; Rath A; Davidson AR
J Mol Biol; 2008 Mar; 377(3):889-901. PubMed ID: 18280496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
